WELL Health: The Future of Healthcare

April 21, 2021

Technology to empower and support patients and doctors

WELL Health is an omni-channel digital health company. Their objective is to empower doctors to provide the best and most advanced care possible while leveraging the latest trends in digital health.  As such, WELL owns and operates 27 primary healthcare clinics in both Canada and the US. In addition, they operate a multi-national digital Electronic Medical Records (EMR) business serving thousands of healthcare clinics of all sizes. They also operate a high quality telehealth service in both Canada and the United States. Further, they are a provider of digital health, billing and cybersecurity related technology solutions. WELL is an acquisitive company that follows a disciplined and accretive capital allocation strategy. 

The company's mission is to positively impact health outcomes by leveraging technology to empower and support patients and doctors.

WELL is pleased to announce that on April 16, 2021, the securityholders of CRH Medical Corporation (“CRH”) approved the acquisition of CRH by a subsidiary of WELL. CRH is a North American company focused on providing gastroenterologists throughout the United States with innovative services and products for the treatment of gastrointestinal diseases.

"CRH is a gamechanger for Wealth. It was valued at CA$460 million and it positions us as a major service provider in the United States and Canada," says Chairman and CEO, Hamed Shahbazi.

For more information on WELL Health Technologies Corp. (TSX: WELL) please click on the request investor info button.

You might also like

Healthcare
Defence Therapeutics: Revolutionizing Immune-Related Therapies with ACCUM Technology

Defence Therapeutics is a Canadian biotech company developing immune-related therapies using their proprietary ACCUM technology.

Healthcare
Investor Alert - Defence Therapeutics: Developing Immune-related Therapies for Cancer Treatment

Defence Therapeutics is a Canadian biotech company developing immune-related therapies for cancer treatment, including cancer vaccines, antibodies, and drug delivery vehicles.

Content Broadcast on: BNN Bloomberg, CNBC, Bloomberg, FOX Business News, BIZTV, Reuters, YouTube and more!